Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Zaun, Gregor; Borchert, Sabrina; Metzenmacher, Martin; Lueong, Smiths; Wiesweg, Marcel; Zaun, Yasmin; Pogorzelski, Michael; Behrens, Franziska; Schildhaus, Hans-Ulrich; Virchow, Isabel; Kasper, Stefan; Schuler, Martin; Theurer, Sarah; Liffers, Sven
    Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
    In: European Journal of Cancer (EJC) Jg. 200 (2024) 113540
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 372 - 378
  • Sommerhäuser, Greta; Karthaus, Meinolf; Kurreck, Annika; Ballhausen, Alexej; Meyer-Knees, Johanna W.; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; Fischer V. Weikersthal, Ludwig; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H. S.; Kasper-Virchow, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer : Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212)
    In: International Journal of Cancer Jg. 154 (2024) Nr. 5, S. 863 - 872
  • Keyl, Julius; Bucher, A.; Jungmann, F.; Hosch, R.; Ziller, A.; Armbruster, R.; Malkomes, P.; Reissig, T.M.; Koitka, S.; Tzianopoulos, I.; Keyl, P.; Kostbade, K.; Albers, David; Markus, P.; Treckmann, Jürgen-Walter; Naßenstein, Kai; Haubold, Johannes; Makowski, M.; Forsting, Michael; Baba, Hideo Andreas; Kasper, Stefan; Siveke, Jens T.; Nensa, Felix; Schuler, Martin; Kaissis, G.; Kleesiek, Jens; Braren, R.
    Prognostic value of deep learning-derived body composition in advanced pancreatic cancer : A retrospective multicenter study
    In: ESMO Open Jg. 9 (2024) Nr. 1, 102219
  • Virchow, Isabel; Treckmann, Jürgen-Walter; Prasnikar, Nicole; Linden, Gabriele; Markus, Peter; Schumacher, Brigitte; Albers, David; Herold, Thomas; Ting, Saskia; Schmidt, Hartmut; Radunz, Sonja; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 3, S. 89 - 99
  • Maßmann, M.; Treckmann, Jürgen Walter; Markus, P.; Schumacher, B.; Albers, D.; Ting, Saskia; Mende, B.; Roehrle, J.; Virchow, I.; Rosery, V.; Laue, K.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Schmid, Kurt Werner; Baba, Hideo Andreas; Siveke, Jens; Paul, A.; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Kasper, Stefan
    A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 5085 - 5094
  • Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M.; Liffers, Sven-Thorsten; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens; Wiesweg, Marcel
    Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 4, S. 140 - 150
  • Meric-Bernstam, Funda; Sweis, Randy F.; Kasper, Stefan; Hamid, Omid; Bhatia, Shailender; Dummer, Reinhard; Stradella, Agostina; Long, Georgina V.; Spreafico, Anna; Shimizu, Toshio; Steeghs, Neeltje; Luke, Jason J.; McWhirter, Sarah M.; Müller, Thomas; Nair, Nitya; Lewis, Nancy; Chen, Xinhui; Bean, Andrew; Kattenhorn, Lisa; Pelletier, Marc; Sandhu, Shahneen
    Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas : An Open-Label, Multicenter, Phase Ib Study
    In: Clinical Cancer Research Jg. 29 (2023) Nr. 1, S. 110 - 121
  • Stahler, Arndt; Hoppe, Beeke; Na, Il-Kang; Keilholz, Luisa; Müller, Lothar; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer Von Weikersthal, Ludwig; Goekkurt, Eray; Kasper, Stefan; Kind, Andreas Jay; Kurreck, Annika; Alig, Annabel Helga Sophie; Held, Swantje; Reinacher-Schick, Anke; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 16, S. 2975 - 2987
  • Zensen, Sebastian; Bücker, Arno; Meetschen, Mathias; Haubold, Johannes; Opitz, Marcel; Theysohn, Jens; Schramm, Sara; Jochheim, Leonie; Kasper, Stefan; Forsting, Michael; Schaarschmidt, Benedikt Michael
    Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors : Lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018–2022
    In: European Radiology (2023) in press
  • Keyl, Julius; Hosch, René; Berger, Aaron; Ester, Oliver; Greiner, Tobias; Bogner, Simon; Treckmann, Jürgen; Ting, Saskia; Schumacher, Brigitte; Albers, David; Markus, Peter; Wiesweg, Marcel; Forsting, Michael; Nensa, Felix; Schuler, Martin; Kasper, Stefan; Kleesiek, Jens
    Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer
    In: Journal of Cachexia, Sarcopenia and Muscle Jg. 14 (2023) Nr. 1, S. 545 - 552
  • Sommerhäuser, Greta; Kurreck, Annika; Beck, Alexander; Fehrenbach, Uli; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; v. Weikersthal, Ludwig F.; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H.S.; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer : An analysis of the PanaMa trial (AIO KRK 0212)
    In: European Journal of Cancer (EJC) Jg. 178 (2023) S. 37 - 48
  • Psyrri, A.; Fayette, J.; Harrington, K.; Gillison, M.; Ahn, M.-J.; Takahashi, S.; Weiss, J.; Machiels, J.-P.; Baxi, S.; Vasilyev, A.; Karpenko, A.; Dvorkin, M.; Hsieh, C.-Y.; Thungappa, S.C.; Segura, P.P.; Vynnychenko, I.; Haddad, R.; Kasper, Stefan; Mauz, P.-S.; Baker, V.; He, P.; Evans, B.; Wildsmith, S.; Olsson, R.F.; Yovine, A.; Kurland, J.F.; Morsli, N.; Seiwert, T.Y.
    Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck : KESTREL, a randomized, open-label, phase III study
    In: Annals of Oncology Jg. 34 (2023) Nr. 3, S. 262 - 274
  • Stintzing, Sebastian; Heinrich, Kathrin; Tougeron, David; Modest, Dominik Paul; Schwaner, Ingo; Eucker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Müller, Christian; Burkart, Christof; Reinacher-Schick, Anke; Kasper-Virchow, Stefan; Fischer von Weikersthal, Ludwig; Krammer-Steiner, Beate; Prager, Gerald Wolfgang; Taieb, Julien; Heinemann, Volker
    FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V⁶⁰⁰E-Mutant Metastatic Colorectal Cancer : The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 25, S. 4143 - 4153
  • Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael
    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 11, S. 9243 - 9252
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 711 - 716
  • Dasari, Arvind; Lonardi, Sara; Garcia-Carbonero, Rocio; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto; Yao, James; García-Alfonso, Pilar; Kocsis, Judit; Cubillo Gracian, Antonio; Sartore-Bianchi, Andrea; Satoh, Taroh; Randrian, Violaine; Tomasek, Jiri; Chong, Geoff; Paulson, Andrew Scott; Masuishi, Toshiki; Jones, Jeremy; Csőszi, Tibor; Cremolini, Chiara; Ghiringhelli, Francois; Shergill, Ardaman; Hochster, Howard S; Krauss, John; Bassam, Ali; Ducreux, Michel; Elme, Anneli; Faugeras, Laurence; Kasper, Stefan; Van Cutsem, Eric; Arnold, Dirk; Nanda, Shivani; Yang, Zhao; Schelman, William R; Kania, Marek; Tabernero, Josep; Eng, Cathy
    Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2) : an international, multicentre, randomised, double-blind, phase 3 study
    In: Lancet Jg. 402 (2023) Nr. 10395, S. 41 - 53
  • Ballhausen, Alexej; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Sommerhäuser, Greta; Alig, Annabel Helga Sophie; Goekkurt, Eray; Meyer-Knees, Johanna Wanda; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Kasper, Stefan; Heinrich, Kathrin; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy : A prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial
    In: European Journal of Cancer (EJC) Jg. 190 (2023) 112955
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 4315 - 4325
  • Zurloh, M.; Goetz, M.; Herold, T.; Treckmann, Jürgen-Walter; Markus, P.; Schumacher, B.; Albers, D.; Rink, A.; Rosery, V.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Ting, S.; Schmidt, H.; Stiens, R.; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    Impact of encorafenib on survival of patients with BRAFV⁶⁰⁰E-mutant metastatic colorectal cancer in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 14, S. 12903 - 12912
  • Grapatsas, Konstantinos; Dörr, Fabian; Menghesha, Hruy; Schuler, Martin; Grünwald, Viktor; Bauer, Sebastian; Schmidt, Hartmut H. -J.; Lang, Stephan; Kimmig, Rainer; Kasper, Stefan; Baldes, Natalie; Bölükbas, Servet
    New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
    In: Cancers Jg. 15 (2023) Nr. 17, 4355
  • Kasper, Stefan; Foch, Caroline; Esser, Regina; Lamy, Francois-Xavier; Zhang, Aimar; Cheng, Ann-Lii; Rouyer, Magali; Brodowicz, Thomas; Zielinski, Christoph
    Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location
    In: European Journal of Cancer (EJC) Jg. 180 (2023) S. 85 - 88
  • Civan, Caner; Kasper, Stefan; Berliner, Christoph; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, Michael; Schaarschmidt, Benedikt Michael; Lang, Stephan; Kersting, David; Nader, Michael; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel
    PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 372 - 378
  • Van Cutsem, Eric; Yaeger, Rona; Delord, Jean-Pierre; Tabernero, Josep; Siu, Lillian L; Ducreux, Michel; Siena, Salvatore; Elez, Elena; Kasper, Stefan; Zander, Thomas; Steeghs, Neeltje; Murphy, Danielle; Edwards, Michelle; Wainberg, Zev A
    Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer
    In: The Oncologist Jg. 28 (2023) Nr. 12, S. e1209 - e1218
  • Schaarschmidt, Benedikt M.; Kloeckner, Roman; Dertnig, Thomas; Demircioglu, Aydin; Müller, Lukas; Auer, Timo Alexander; Santos, Daniel Pinto Dos; Steinle, Verena; Miederer, Matthias; Gebauer, Bernhard; Radunz, Sonia; Kasper, Stefan; Weber, Manuel; Theysohn, Jens
    Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by ⁹⁰Y Radioembolization : A Multicenter Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 4, S. 529 - 535
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1191 - 1194
  • Reissig, T.M.; Tzianopoulos, I.; Liffers, S.-T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, Marcel; Kasper, S.; Meister, P.; Herold, T.; Schmidt, H.H.; Schumacher, B.; Albers, David; Markus, P.; Treckmann, J.; Schuler, Martin; Schildhaus, Hans-Ulrich; Siveke, Jens
    Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancer
    In: ESMO Open Jg. 8 (2023) Nr. 3, 101539
  • Pabst, Kim M.; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Ballke, Simone; Steiger, Katja; Bartel, Timo; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Seifert, Robert; Nader, Michael; Kessler, Lukas; Siveke, Jens; Lückerath, Katharina; Kasper, Stefan; Herrmann, Ken; Hirmas, Nader; Schmidt, Hartmut; Hamacher, Rainer; Fendler, Wolfgang
    Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1049 - 1055
  • Hofheinz, Ralf; Arnold, Dirk; Fichtner-Feigl, Stefan; Fokas, Emmanouil; Folprecht, Gunnar; Geissler, Michael; Ghadimi, Michael; Hegewisch-Becker, Susanne; Heinemann, Volker; Kasper-Virchow, Stefan; Kubicka, Stefan; Modest, Dominik Paul; Piso, Pompilio; Reinacher-Schick, Anke; Rödel, Claus-Michael; Seufferlein, Thomas; Stein, Alexander; Stintzing, Sebastian
    Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“
    In: Der Onkologe Jg. 28 (2022) Nr. Suppl. 1, S. 44 - 49
  • Modest, Dominik Paul; Karthaus, Meinolf; Kasper, Stefan; Moosmann, Nicolas; Keitel, Verena; Kiani, Alexander; Uhlig, Jens; Jacobasch, Lutz; Fischer v. Weikersthal, Ludwig; Fuchs, Martin; Kaiser, Florian; Lerchenmüller, Christian; Sent, Dagmar; Junghanß, Christian; Held, Swantje; Lorenzen, Sylvie; Kaczirek, Klaus; Jung, Andreas; Stintzing, Sebastian; Heinemann, Volker
    FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases : The PARLIM trial (AIO KRK 0314)
    In: European Journal of Cancer (EJC) Jg. 173 (2022) S. 297 - 306
  • Rink, Andreas D.; Kasper, Stefan
    Heilung ohne Operation und Radiochemotherapie beim lokal fortgeschrittenen, Mismatch-Reparatur-defizienten Rektumkarzinom?
    In: Coloproctology Jg. 44 (2022) Nr. 5, S. 357 - 360
  • Gillison, Maura L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Jayaprakash, Vijayvel; Wei, Li; Ferris, Robert L
    Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer : Subgroup Analysis of CheckMate 141
    In: The Oncologist Jg. 27 (2022) Nr. 2, S. e194 - e198
  • Keyl, J.; Kasper, S.; Wiesweg, Marcel; Götze, J.; Schönrock, M.; Sinn, M.; Berger, A.; Nasca, E.; Kostbade, K.; Schumacher, B.; Markus, P.; Treckmann, Jürgen-Walter; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Kleesiek, J.
    Multimodal survival prediction in advanced pancreatic cancer using machine learning
    In: ESMO Open Jg. 7 (2022) Nr. 5, 100555
  • Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stefanie E.; Weber, Wolfgang A.; Haller, Bernhard; Angele, Martin; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Schmid, Roland M.; Bassermann, Florian; Schwaiger, Markus; Liffers, Sven-Thorsten; Siveke, Jens
    PET-directed combined modality therapy for gastroesophageal junction cancer : Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK)
    In: European Journal of Cancer (EJC) Jg. 175 (2022) S. 99 - 106
  • Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja
    Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer : The Randomized PANAMA Trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 1, S. 72 - 82
  • Trojan, Jörg; Hoffmeister, Albrecht; Neu, Bruno; Kasper, Stefan; Dechene, Alexander; Jürgensen, Christian; Schirra, Jörg; Jakobs, Ralf; Palmer, Dan; Selbo, Pål; Olivecrona, Hans; Finnesand, Lena; Høgset, Anders; Walday, Per; Sturgess, Richard
    Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma
    In: The Oncologist Jg. 27 (2022) Nr. 6, S. 430 - 431, e423 - e433
  • Kumbrink, Jörg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstöcker, Daniela; Li, Pan; Lorenzen, Sylvie; Algül, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; von Bergwelt-Baildon, Michael; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker; Holch, Julian W.
    Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer : Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL
    In: Cancers Jg. 14 (2022) Nr. 15, 3631
  • Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker; Holch, Julian Walter; Maderer, Annett; Kasper, Stefan; Hegewisch‐Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Geißler, Michael; Schulz‐Abelius, Armin; Linz, Bernhard; Bernhard, Helga; Paul, Andreas; Schmidtmann, Irene; Potthoff, Karin; Schimanski, Carl Christoph
    Survival after secondary liver resection in metastatic colorectal cancer : Comparing data of three prospective randomized European trials ( LICC , CELIM , FIRE ‐3)
    In: International Journal of Cancer Jg. 150 (2022) Nr. 8, S. 1341 - 1349
  • Guberina, Nika; Kessler, Lukas; Pöttgen, Christoph; Guberina, Maja; Metzenmacher, Martin; Herrmann, Ken; Mucha, Maja; Rischpler, Christoph; Indenkämpen, Frank; Siveke, Jens; Treckmann, Jürgen-Walter; Umutlu, Lale; Kasper, Stefan; Fendler, Wolfgang; Stuschke, Martin
    ⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 16261
  • Folprecht, Gunnar; Trautmann, Karolin; Stein, Alexander; Huebner, Gerdt; Stahl, Michael; Kasper, Stefan; Kretzschmar, Albrecht; Köhne, Claus-Henning; Grünwald, Viktor; Hofheinz, Ralf-Dieter; Schütte, Katharina; Löffler, Harald; Bokemeyer, Carsten; Krämer, Alwin
    Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP) : Results of the Phase 2 AIO trial PACET-CUP
    In: British Journal of Cancer (BJC) Jg. 124 (2021) Nr. 4, S. 721 - 727
  • Rosery, Vivian; Reis, Henning; Savvatakis, Konstantinos; Kowall, Bernd; Stuschke, Martin; Paul, Andreas; Dechene, Alexander; Yang, JiaJin; Zhao, Ben; Borgers, Arianna; Kasper, Stefan; Schuler, Martin; Cheung, Phyllis F.; Siveke, Jens
    Antitumor immune response is associated with favorable survival in GEP-NEN G3
    In: Endocrine-Related Cancer Jg. 28 (2021) Nr. 10, S. 683 - 693
  • Frikkel, Johanna; Beckmann, Mingo B.; de Lazzari, Nico; Götte, Miriam; Kasper, Stefan; Hense, Jörg; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative study
    In: Supportive Care in Cancer Jg. 29 (2021) Nr. 9, S. 5127 - 5137
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 2, S. 579 - 591
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trial
    In: Radiation Oncology Jg. 16 (2021) Nr. 1, S. 59
  • Adamczyk, Alexandra; Pastille, Eva; Kehrmann, Jan; Vu, Vivian P.; Geffers, Robert; Wasmer, Marie-Hélène; Kasper, Stefan; Schuler, Martin; Lange, Christian; Muggli, Beat; Rau, Tilman T.; Klein, Diana; Hansen, Wiebke; Krebs, Philippe; Buer, Jan; Westendorf, Astrid
    GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancer
    In: Cancer Research Jg. 81 (2021) Nr. 11, S. 2970 - 2982
  • Pogorzelski, Michael; Hilser, Thomas; Ting, Saskia; Kansy, Benjamin; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Grünwald, Viktor; Schuler, Martin; Kasper, Stefan
    Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
    In: Frontiers in Oncology Jg. 11 (2021) 635096
  • Kasper, Stefan; Foch, Caroline; Messinger, Diethelm; Esser, Regina; Lamy, Francois-Xavier; Rothe, Vivien; Chen, Wenfeng; Cheng, Ann-Lii; Rouyer, Magali; Brodowicz, Thomas; Zielinski, Christoph
    Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer
    In: European Journal of Cancer (EJC) Jg. 144 (2021) S. 291 - 301
  • Delord, Jean-Pierre; Argilés, Guillem; Fayette, Jerôme; Wirth, Lori; Kasper, Stefan; Siena, Salvatore; Mesia, Ricard; Berardi, Rossana; Cervantes, Andrés; Dekervel, Jeroen; Zhao, Sylvia; Sun, Yongjian; Hao, Huai-Xiang; Tiedt, Ralph; Vicente, Sergio; Myers, Andrea; Siu, Lillian L.
    A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment
    In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 38 (2020) S. 1774 - 1783
  • Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Heinemann, Volker; Geißler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schön, Michael R.; Greil, Richard; Galle, Peter; Lang, Hauke; Schmidtmann, Irene; Moehler, Markus
    Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases : A randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
    In: OncoImmunology Jg. 9 (2020) Nr. 1, 1806680
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer Jg. 19 (2020) Nr. 4, S. 236 - 247.e6
  • Pape, Ulrich-Frank; Kasper, Stefan; Meiler, Johannes; Sinn, Marianne; Vogel, Arndt; Müller, Lothar; Burkhard, Oswald; Caca, Karel; Heeg, Steffen; Büchner-Steudel, Petra; Rodriguez-Laval, Victor; Kühl, Anja A.; Arsenic, Ruza; Jansen, Holger; Treasure, Peter; Utku, Nalân
    Effcacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers : Data from a randomised phase II study
    In: Cancers Jg. 12 (2020) Nr. 11, S. 1 - 16
  • Frikkel, Johanna; Götte, Miriam; Beckmann, Mingo B.; Kasper, Stefan; Hense, Jörg; Teufel, Martin; Schuler, Martin; Tewes, Mitra
    Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients
    In: BMC Palliative Care Jg. 19 (2020) Nr. 1, S. 43
  • Becker, Matthias; Böckmann, Britta; Jöckel, Karl-Heinz; Stuschke, Martin; Paul, Andreas; Kasper, Stefan; Virchow, Isabel
    Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment
    In: Applied Clinical Informatics Jg. 11 (2020) Nr. 2, S. 200 - 209
  • Dechene, Alexander; Kasper, Stefan; Olivecrona, Hans; Schirra, Joerg; Trojan, Joerg
    Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
    In: Endoscopy International Open Jg. 08 (2020) Nr. 12, S. E1878 - E1883
  • Attenberger, Ulrike; Rödel, Claus; Ghadimi, Michael; Piso, Pompilio; Arnold, Dirk; Folprecht, Gunnar; Geissler, Michael; Hegewisch-Becker, Susanna; Heinemann, Volker; Kasper, Stefan; Modest, Dominik; Reinacher-Schick, Anke; Seufferlein, Thomas; Stein, Alexander; Stintzing, Sebastian; Hofheinz, Ralf-Dieter
    Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom - Interdisziplinäre Empfehlungen
    In: Zeitschrift für Gastroenterologie Jg. 58 (2020) Nr. 6, S. 577 - 582
  • Attenberger, U.I.; Rödel, C.; Ghadimi, M.; Piso, P.; Arnold, D.; Folprecht, G.; Geissler, M.; Hegewisch-Becker, S.; Heinemann, V.; Kasper, Stefan; Modest, D.; Reinacher-Schick, A.; Seufferlein, T.; Stein, A.; Stintzing, S.; Hofheinz, R.
    Stellenwert und qualitative Voraussetzungen der Magnetresonanztomographie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – interdisziplinäre Empfehlungen
    In: Best Practice Onkologie Jg. 15 (2020) Nr. 7-8, S. 300 - 306
  • Kasper, Stefan; Virchow, Isabel; Hadaschik, Boris; Radtke, Jan Philipp
    Was erwartet der Nichtradiologe vom Radiologen?
    In: Der Radiologe Jg. 60 (2020) Nr. 5, S. 421 - 429
  • Kasper, Stefan; Hussain, Timon; Virchow, Isabel; Stuschke, Martin; Lang, Stephan
    Immunonkologie von Kopf-Hals-Tumoren
    In: HNO Jg. 67 (2019) Nr. 3, S. 221 - 235
  • Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt Werner; Schuler, Martin
    Impact of RAS mutation subtype on clinical outcome : a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    In: Oncogene Jg. 38 (2019) Nr. 16, S. 2953 - 2966
  • Juntermanns, Benjamin; Kaiser, Gernot Maximil; Reis, Henning; Gries, Silvia; Kasper, Stefan; Paul, Andreas; Canbay, Aliekber; Fingas, Christian
    Long-term Survival after resection for perihilar cholangiocarcinoma : Impact of UICC staging and surgical procedure
    In: The Turkish Journal of Gastroenterology Jg. 30 (2019) Nr. 5, S. 454 - 460
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Wiesweg, Marcel; Köhler, Johannes; Markus, M.; Mende, B.; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
    In: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 2, S. 445 - 455
  • Becker, Matthias; Kasper, Stefan; Böckmann, Britta; Jöckel, Karl-Heinz; Virchow, Isabel
    Natural Language Processing of German Clinical Colorectal Cancer Notes for Guideline-Based Treatment Evaluation
    In: International Journal of Medical Informatics Jg. 127 (2019) S. 141 - 146
  • Haddad, Robert; Concha-Benavente, Fernando; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Kasper, Stefan; Vokes, Everett E.; Worden, Francis; Saba, Nabil F.; Tahara, Makoto; Jayaprakash, Vijayvel; Lynch, Mark; Li, Li; Gillison, Maura L.; Harrington, Kevin J.; Ferris, Robert L.
    Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141 : A subgroup analysis of a randomized phase 3 clinical trial
    In: Cancer Jg. 125 (2019) Nr. 18, S. 3208 - 3218
  • Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Jörg; Koenigsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Löhr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; Weikersthal, Ludwig Fischer von; Hartmann, Jörg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Jörg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Güntner, Martina; Hozaeel, Wael; Reichart, Alexander; Jäger, Elke; Kraus, Thomas; Mönig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald; Hofheinz, Ralf D.
    Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) : A randomised, phase 2/3 trial
    In: Lancet Jg. 393 (2019) Nr. 10184, S. 1948 - 1957
  • Pape, Ulrich-Frank; Kasper, Stefan; Meiler, Johannes; Sinn, Marianne; Vogel, Arndt; Mueller, Lothar; Burkhard, Oswald; Caca, Karel; Heeg, Steffen; Laval, Victor Rodriguez; Kühl, Anya A; Arsenic, Ruza; Jansen, Holger; Utku, Nalan
    Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 4_Suppl, S. 264 - 264
  • Pastille, Eva; Wasmer, Marie-Hélène; Adamczyk, Alexandra; Vu, Vivian P.; Mager, Lukas F.; Phuong, Nhi Ngo Thi; Palmieri, Vittoria; Simillion, Cedric; Hansen, Wiebke; Kasper, Stefan; Schuler, Martin; Muggli, Beat; McCoy, Kathy D.; Buer, Jan; Zlobec, Inti; Westendorf, Astrid; Krebs, Philippe
    The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
    In: Mucosal Immunology Jg. 12 (2019) Nr. 4, S. 990 - 1003
  • Seufferlein, Thomas; Lausser, Ludwig; Stein, Alexander; Prager, Gerald W.; Kasper, Stefan; Niedermeier, M.; Müller, Lothar; Kubicka, Stefan; König, Alexander O.; Büchner-Steudel, Petra; Wille, Kai; Perkhofer, Lukas; Hann, Alexander; Berger, Andreas W.; Arnold, Dirk; Kestler, Hans Armin; Ettrich, Thomas J.
    A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab : First results of the PERMAD trial
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii159
  • Juntermanns, Benjamin; Kaiser, Gernot Maximil; Itani Gutierrez, S.; Heuer, Matthias; Büchter, Matthias; Kahraman, Alisan; Reis, Henning; Kasper, Stefan; Paul, Andreas; Fingas, Christian
    CA19-9 beim intrahepatischen Cholangiokarzinom : Ein diagnostisches und prognostisches Armamentarium?
    In: Der Chirurg Jg. 89 (2018) Nr. 6, S. 466 - 471
  • Gillison, Maura L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Monga, Manish; Lynch, Mark; Li, Li; Ferris, Robert L.
    CheckMate 141 : 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
    In: The Oncologist Jg. 23 (2018) Nr. 9, S. 1079 - 1082
  • Juntermanns, Benjamin; Kaiser, Gernot Maximil; Orth, Lena; Reis, Henning; Jaradat, Derar; Sydor, Svenja; Buechter, Matthias; Kasper, Stefan; Mathé, Zoltan; Sotiropoulos, Georgios Charalambos; Baba, Hideo Andreas; Canbay, Ali; Paul, Andreas; Fingas, Christian
    Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma
    In: European Journal of Medical Research Jg. 23 (2018) Nr. 1, S. 29
  • Kasper, Stefan; Hussain, Timon; Virchow, Isabel; Stuschke, Martin; Lang, Stephan
    Immunonkologie von Kopf-Hals-Tumoren
    In: Best Practice Onkologie Jg. 13 (2018) Nr. 6, S. 336 - 349
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
  • Ferris, Robert L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L.
    Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck : 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
    In: Oral Oncology Jg. 81 (2018) S. 45 - 51
  • Vogel, Arndt; Kasper, Stefan; Bitzer, Michael; Block, Andreas; Sinn, Marianne; Schulze-Bergkamen, Henning; Moehler, Markus; Pfarr, Nicole; Endris, Volker; Goeppert, Benjamin; Merx, Kirsten; Schnoy, Elisabeth; Siveke, Jens; Michl, Patrick; Waldschmidt, Dirk; Kuhlmann, Jan; Geissler, Michael; Kahl, Christoph; Evenkamp, Ralf; Schmidt, Torben; Kuhlmann, Alexander; Weichert, Wilko; Kubicka, Stefan
    PICCA study : panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study
    In: European Journal of Cancer (EJC) Jg. 92 (2018) S. 11 - 19
  • Wiesweg, Marcel; Reis, Henning; Köster, Tobias; Goetz, Moritz; Worm, Karl; Herold, Thomas; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Markus, Peter; Virchow, Isabel; Kostbade, Karina; Wolf, Nathalie; Zaun, Gregor; Metzenmacher, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
    In: Clinical Colorectal Cancer Jg. 17 (2018) Nr. 2, S. e331 - e352
  • Trojan, Jörg; Sturgess, R.; Harrison Palmer, D.; Neu, Bruno; Kasper, Stefan; Dechene, Alexander; Jürgensen, C.; Schirra, J.; Jakobs, Ralf Gerhard; Högset, Anders; Finnesand, L.; Olivecrona, H.
    PhotoChemical internalization of gemcitabine followed by gemcitabine/cisplatin in perihilar cholangiocarcinoma : Results from a phase I dose escalation trial
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii259 - viii260
  • Kasper, Stefan; Kisro, Jens; Fuchs, Martin; Müller, Christian; Schulz-Abelius, Armin; Karthaus, Meinolf; Rafiyan, Mohammad-Reza; Stein, Alexander
    Safety profile of trifluridine/tipiracil monotherapy in clinical practice : results of the German compassionate-use program for patients with metastatic colorectal cancer
    In: BMC Cancer Jg. 18 (2018) S. 1124
  • Soulières, Denis; Faivre, Sandrine; Mesía, Ricard; Remenár, Éva; Li, Shau-Hsuan; Karpenko, Andrey; Dechaphunkul, Arunee; Ochsenreither, Sebastian; Kiss, Laura Anna; Lin, Jin-Ching; Nagarkar, Raj; Tamás, László; Kim, Sung-Bae; Erfán, Jozsef; Alyasova, Anna; Kasper, Stefan; Barone, Carlo; Turri, Sabine; Chakravartty, Arunava; Chol, Marie; Aimone, Paola; Hirawat, Samit; Licitra, Lisa
    Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1) : a randomised, double-blind, placebo-controlled phase 2 trial
    In: The Lancet Oncology Jg. 18 (2017) Nr. 3, S. 323 - 335
  • Concha-Benavente, F.; Gillison, M. L.; Blumenschien, G.; Harrington, K. J.; Fayette, J.; Colevas, A. D.; Licitra, L.; Kasper, Stefan; Even, C.; Worden, F.; Saba, N. F.; Haddad, R.; Tahara, M.; Hasegawa, Y.; Yen, C. J.; Lynch, M.; Monga, M.; Geese, W. J.; Vokes, E. E.; Ferris, R. L.
    Characterisation of Potential Predictive Biomarkers of Response to Nivolumab in Checkmate 141 in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    In: Asia-Pacific Journal of Clinical Oncology Jg. 13 4 (2017) S. 141 - 141
  • Breitenbücher, Frank; Von Pawel, Joachim; Sebastian, Martin; Kortsik, Cornelius; Ting, Saskia; Kasper, Stefan; Wohlschläger, Jeremias; Worm, Karl; Morresi-Hauf, Alicia; Schad, Arno; Westerwick, Daniela; Wehler, Beatrice; Werner, Martin; Munzert, Gerd; Gaschler-Markefski, Birgit; Schmid, Kurt Werner; Schuler, Martin
    Comprehensive biomarker analyses in patients with advanced or metastatic non-small cell lung cancer prospectively treated with the polo-like Kinase 1 Inhibitor BI2536
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. 7-8, S. 435 - 439
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K.; Folprecht, G.; Probst, S.; Thuss-Patience, P.; Trojan, J.; Koenigsmann, M.; Lindig, U.; Pohl, M.; Kasper, Stefan; Hler, M. M.; Goetze, T.; Schuler, Martin; Jaeger, E.; Hofheinz, R. D.
    Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer : Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget Jg. 8 (2017) Nr. 28, S. 45898 - 45917
  • Harrington, Kevin J; Ferris, Robert L; Blumenschein, George; Colevas, A Dimitrios; Fayette, Jérôme; Licitra, Lisa; Kasper, Stefan; Even, Caroline; Vokes, Everett E; Worden, Francis; Saba, Nabil F; Kiyota, Naomi; Haddad, Robert; Tahara, Makoto; Grünwald, Viktor; Shaw, James W; Monga, Manish; Lynch, Mark; Taylor, Fiona; DeRosa, Michael; Morrissey, Laura; Cocks, Kim; Gillison, Maura L; Guigay, Joël
    Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) : health-related quality-of-life results from a randomised, phase 3 trial
    In: The Lancet Oncology Jg. 18 (2017) Nr. 8, S. 1104 - 1115
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K. B.; Schmiegel, W.; Folprecht, G.; Probst, S.; Prasnikar, N.; Thuss-Patience, P.; Fischbach, W.; Trojan, J.; Koenigsmann, M.; Goetze, T. O.; Kraus, T. W.; Battmann, A.; Moenig, S. P.; Bechstein, W.; Gaiser, T.; Tannapfel, A.; Jäger, E.; Schuler, Martin; Lindig, U.; Pohl, M.; Kasper, Stefan; Möhler, M.; Hofheinz, R. D.
    Perioperative chemotherapy with docetaxel, oxaliplatin and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO) : a rando
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 200 - 201
  • Sturgess, R.; Finnesand, L.; Trojan, J.; Jürgensen, C.; Palmer, D.; Høgset, A.; Jakobs, R.; Hoffmeister, A.; Neu, B.; Kasper, Stefan; Schirra, J.; Dechene, Alexander
    Phase I clinical study with photochemical internalisation, a novel technology for treatment of perihilar cholangiocarcinoma
    In: Journal of Hepatology Jg. 66 (2017) Nr. 1, S. S452
  • Kalkavan, Halime; Sharma, Piyush; Kasper, Stefan; Helfrich, Iris; Pandyra, Aleksandra A.; Gassa, Asmae; Virchow, Isabel; Flatz, Lukas; Brandenburg, Tim; Namineni, Sukumar; Heikenwalder, Mathias; Höchst, Bastian; Knolle, Percy A.; Wollmann, Guido; Von Laer, Dorothee; Drexler, Ingo; Rathbun, Jessica; Cannon, Paula M.; Scheu, Stefanie; Bauer, Jens; Chauhan, Jagat; Häussinger, Dieter; Willimsky, Gerald; Löhning, Max; Schadendorf, Dirk; Brandau, Sven; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regression
    In: Nature Communications Jg. 8 (2017) S. 14447
  • Kasper, Stefan; Haddad, R.; Ferris, R. L.; Blumenschein, G.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Vokes, E. E.; Worden, F.; Saba, N. F.; Tahara, M.; Monga, M.; Lynch, M.; Zhu, J.; Shaw, J. W.; Gillison, M. L.; Harrington, K. J.
    Treatment beyond progression with nivolumab (nivo) in patients with recurrent or metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the phase 3 CheckMate 141 study
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 250 - 251
  • Dechene, Alexander; Kasper, Stefan
    Cholangiozelluläres Karzinom : Interventionelle und systemische Therapieoptionen
    In: Der Gastroenterologe Jg. 11 (2016) Nr. 5, S. 400 - 409
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    In: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805
  • Stintzing, S.; Modest, D. P.; Jung, A.; Kirchner, T.; Schafer, R.; Sers, C.; Hildebrandt, B.; Daum, S.; Folprecht, G.; Schuler, Martin; Kasper, Stefan; Trojan, J.; Jaeger, D.; Schulze-Bergkamen, H.; von Weikersthal, L. F.; Schalhorn, A.; Heinemann, V.
    Differences in gene-expression in mCRC tissue samples with regard to tumor location and used chemotherapeutic substances : Data of the FIRE-1 study
    In: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. Suppl. 4, S. 562
  • Juntermanns, B; Fingas, Christian; Sotiropoulos, Georgios; Jaradat, D; Dechene, Alexander; Reis, H; Kasper, Stefan; Paul, Andreas; Kaiser, Gernot Maximil
    Klatskin-Tumor : Langzeitüberleben nach Operation
    In: Der Chirurg Jg. 87 (2016) Nr. 6, S. 514 - 519
  • Ferris, Robert L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Iglesias Docampo, Lara C; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Monga, Manish; Lynch, Mark; Geese, William J; Kopit, Justin; Shaw, James W; Gillison, Maura L
    Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    In: The New England Journal of Medicine Jg. 375 (2016) Nr. 19, S. 1856 - 1867
  • Modest, D.P.; Kasper, Stefan; Stintzing, S.; Prasnikar, N.; Müller, L.; Caca, K.; Gökkurt, E.; von Weikersthal, L. Fischer; Kopp, H.-G.; Trarbach, Tanja
    Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RAS WT metastatic colorectal cancer
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 605TiP
  • Utku, Nalan; Kuhlmann, Jan; Kasper, Stefan; Pape, Ulrich-Frank; Vogel, Arndt; Sinn, Marianne; Keilholz, Ulrich; Caca, Karel
    Randomized, multicenter phase II trial of CAP7.1 in patients with advanced biliary tract cancers.
    In: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. Suppl. 4, S. 441 - 441
  • Hoya, V.; Stuschke, Martin; Sauerwein, Wolfgang; Bornfeld, Norbert; Metz, Klaus; Schuler, Martin; Kasper, Stefan
    Small cell neuroendocrine carcinoma of the right eye : A case report
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 189 - 189
  • Klümpen, H.J.; Nashan, B.; Shannon, J.; Primrose, J.; Kasper, Stefan; Goldstein, D.; Wege, H.; Sinn, M.; Arnold, D.; Stein, A.; Weiss, K.H.; Bechstein, W.O.; Rentsch, M.; Bridgewater, J.; Jensen, L.H.; Kunzmann, V.; Lindig, U.; Lohse, A.W.
    Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1) – a randomized, multidisciplinary, multinational phase III trial
    In: Journal of Hepatology Jg. 62 (2015) Nr. Suppl. 2, S. S845
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Ting, Saskia; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kosbade, Karina; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) : Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15 Suppl., S. 3568
  • Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel
    HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas
    In: Lung Cancer Jg. 88 (2015) Nr. 1, S. 34 - 41
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, Stephan; Bergmann, Christoph; Brandau, Sven; Abu-Jawad, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies
    In: Oral Oncology Jg. 51 (2015) Nr. 5, S. e39
  • Breitenbücher, Frank; Hoffarth, Sandra; Worm, Karl; Cortes-Incio, Diana; Gauler, Thomas; Köhler, Jens; Herold, Thomas; Kurt Werner, Schmid; Freitag, Lutz; Kasper, Stefan; Schuler, Martin
    Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
    In: PLoS ONE Jg. 9 (2014) Nr. 1, S. e85350
  • Kohler, J.; Schuler, Martin; Kasper, Stefan; Nensa, Felix; Hense, Jörg; Forsting, Michael; Kuhl, H.
    Formation of multiple pneumatoceles during anti-angiogenic treatment for metastatic colorectal cancer
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 84 - 85
  • Göbel, C.; Breitenbücher, Frank; Kalkavan, H.; Hähnel, Patricia S.; Kasper, Stefan; Hoffarth, Christian; Merches, Katja; Schild, Hans-Jörg; Lang, Karl S.; Schuler, Martin
    Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity
    In: Cell Death and Disease Jg. 5 (2014) Nr. 12, 1568
  • Pogorzelski, M-; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, Christoph; Brandau, Sven; Abu Jawad, Jehad; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
    In: Cell Death and Disease Jg. 5 (2014) Nr. 2, e1091
  • Kasper, Stefan; Schuler, Martin
    Targeted therapies in gastroesophageal cancer
    In: European Journal of Cancer (EJC) Jg. 50 (2014) Nr. 7, S. 1247 - 1258
  • Pastille, Eva; Bardini, Katrin; Fleissner, Diana; Adamczyk, Alexandra; Frede, Annika; Wadwa, Munisch; Smolinski, Dorthe von; Kasper, Stefan; Sparwasser, Tim; Gruber, Achim D.; Schuler, Martin; Sakaguchi, Shimon; Roers, Axel; Müller, Werner; Hansen, Wiebke; Buer, Jan; Westendorf, Astrid
    Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer
    In: Cancer Research Jg. 74 (2014) Nr. 16, S. 4258 - 4269
  • Caldarelli, Antonio; Müller, Jörg P.; Paskowski-Rogacz, M.; Herrmann, Ken; Bauer, Reinhard F.; Koch, Sina; Heninger, Anne Kristin; Krastev, Dragomir Blazhev; Ding, Li; Kasper, Stefan; Fischer, Thomas A.; Brodhun, Michael; Böhmer, Frank Dietmar; Buchholz, Frank
    A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
    In: Leukemia Jg. 27 (2013) Nr. 12, S. 2301 - 2310
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) : An interim analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. e14502
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082
  • Kasper, Stefan; Breitenbücher, Frank; Reis, Henning; Brandau, Sven; Worm, K.; Köhler, J.; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Schuler, Martin
    Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade
    In: Oncogene Jg. 32 (2013) Nr. 23, S. 2873 - 2881
  • Welt, Anja; Tewes, Mitra; Aktas, Bahriye; Hoffmann, Oliver; Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Richly, Heike; Hense, Jörg; Palmer, Michael R.; Lee, Benjamin H.; Wendling, Johanna; Kossow, Josef; Scheulen, Max Ernst; Lehnerdt, Cathrin; Kohl, Marzena; Derks, Cordula; Skottky, Silke; Haus, Ulrike; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Kasper, Stefan
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88
  • Molzan, M.; Kasper, Stefan; Röglin, L.; Skwarczynska, M.; Sassa, T.; Inoue, T.; Breitenbücher, Frank; Ohkanda, J.; Kato, N.; Schuler, Martin; Ottmann, C.
    Stabilization of Physical RAF/14-3-3 Interaction by Cotylenin A as Treatment Strategy for RAS Mutant Cancers
    In: ACS Chemical Biology Jg. 8 (2013) Nr. 9, S. 1869 - 1875
  • Kasper, Stefan; Meiler, Johannes; Schuler, Martin
    Antikörper zur adoptiven Immuntherapie solider Tumoren
    In: Der Onkologe Jg. 18 (2012) Nr. 9, S. 757 - 769
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Vossebein, I.; Breitenbucher, F.; Lang, Stephan; Hoffmann, T. K.; Bergmann, Christoph; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximab
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 193 - 193
  • Schimanski, Carl C.; Möhler, Markus; Schön, Michael; van Cutsem, Eric; Greil, Richard; Bechstein, Wolf O.; Hegewisch-Becker, Susanna; von Wichert, Götz; Vöhringer, Matthias; Heike, Michael; Heinemann, Volker; Peeters, Marc; Kanzler, Stephan; Kasper, Stefan; Overkamp, Friedrich; Schröder, Jan; Seehofer, Daniel; Kullmann, Frank; Linz, Bernhard; Schmidtmann, Irene; Smith-Machnow, Victoria; Gockel, Ines; Lang, Hauke; Galle, Peter R.
    LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
    In: BMC Cancer Jg. 12 (2012) S. 144
  • Markova, Boyka; Hähnel, Patricia S.; Kasper, Stefan; Herbertz, Stephan; Schuler, Martin; Breitenbücher, Frank
    Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 4, S. 545 - 554
  • Kasper, Stefan; Breitenbücher, Frank; Heidel, F.; Hoffarth, S.; Markova, B.; Schuler, Martin; Fischer, T.
    Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
    In: Blood Cancer Journal Jg. 2 (2012) Nr. 3, S. e60
  • Kasper, Stefan; Reis, Henning; Breitenbücher, Frank; Markowetz, J.; Pogorzelski, M.; Trarbach, Tanja; Worm, K.; Schmid, Kurt Werner; Schuler, Martin
    Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 253
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 5, S. 823 - 830
  • Aktas, B.; Kasimir-Bauer, Sabine; Kasper, Stefan; Derks, C.; Kimmig, Rainer; Schuler, Martin; Tewes, Mitra
    Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative Therapy
    In: Cancer Research Jg. 71 (2011) Nr. Suppl. 24,
  • Christoph, DanielC; Kasper, Stefan; Gauler, ThomasC; Breitenbücher, Frank; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Hirsch, FredR; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1078
  • Breitenbücher, Frank; Hoffarth, S.; Gauler, Thomas; Stergar, S. L.; Kasper, Stefan; Kohler, J.; Worm, K.; Marten, A.; Schmid, Kurt Werner; Schuler, Martin
    Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S956 - S957
  • Kasper, Stefan; Breitenbücher, Frank; Even, A.; Pogorzelski, M.; Hoffarth, S.; Stergar, S. L.; Trarbach, Tanja; Schuler, Martin
    Pharmacological Inhibition of NF-k and PLK-1 to the Opening of the RAS-mediated Resistance to anti-EGFR Antibody therapies in Colorectal cancer *
    In: Der Internist Jg. 52 (2011) Nr. 6, S. 726 - 726
  • Schuler, Martin; Breitenbücher, Frank; Trarbach, Tanja; Brandau, Sven; Schmid, Kurt Werner; Kasper, Stefan
    Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RAS
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. Suppl. 4, S. 440
  • Vorworte / Nachworte

  • Kasper, Stefan; Rammensee, Hans-Georg; Gaipl, Udo; Höffken, Klaus
    Tumor immunology : The new fourth pillar of tumor treatment
    In: Der Onkologe Jg. 27 (2021) Nr. 11, S. 1046 - 1048
  • Abstracts

  • Pogorzelski, Michael; Klinghammer, K.; Hilser, Thomas; Kasper, Stefan; Grünwald, Viktor; et al.;
    Analysis of ecacy and treatment pattern of second-line therapy after failure of immunotherapy-based treatment in recurrent or metastatic head and neck squamous cell carcinoma (r/m SCCHN) using the head and neck clinical research platform (HEAT)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 244
  • Stockey, M.; Treckmann, Jürgen-Walter; Rink, A.; Schmidt, H.; Markus, Peter; Albers, David; Zaun, G.; Kostbade, K.; Hilser, T.; Pogorzeslki, M.; Baba, Hideo Andreas; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.;
    HER2-low as potential prognostic biomarker in patients (pts) with metastatic or recurrent Gastric Cancer (GC) or esophageal-gastric junction (AEG) adenocarcinoma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 117 - 118
  • Hoppe, Beeke; Modest, Dominik Paul; Keilholz, Luisa; Na, Il-Kang; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Von Weikersthal, Ludwig Fischer; Goekkurt, Eray; Reinacher-Schick, Anke C.; Kasper, Stefan; Kind, Andreas Jay; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    Consensus molecular subtypes (CMS) as prognostic and predictive biomarkers of panitumumab (Pmab), fluorouracil and folinic acid (FU/FA) or FU/FA maintenance therapy following Pmab-FOLFOX induction in RAS wildtype metastatic colorectal cancer (mCRC) : PANAMA trial (AIO-KRK-0212)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 3537
  • Kind, Andreas Jay; Modest, Dominik Paul; Sers, Christine; Mamlouk, Soulafa; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Von Weikersthal, Ludwig Fischer; Goekkurt, Eray; Reinacher-Schick, Anke C.; Kasper, Stefan; Kurreck, Annika; Hoppe, Beeke; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC) : Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 3536
  • Segal, N.; Rivera, F.; Tournigand, C.; Kasper, Stefan; Chen, Y.; Deshpande, P.; Messmann, R.; Kopetz, S.
    P-23 Phase II study (daNIS-3) of the anti–TGF-β monoclonal antibody NIS793 and other new investigational drug combinations with standard-of-care therapy vs standard-of-care alone in patients with second-line metastatic colorectal cancer
    In: Annals of Oncology Jg. 33 (2022) S. 254 - S255
  • Civan, C.; Kasper, Stefan; Berliner, C.; Fragoso-Costa, P.; Grünwald, V.; Pogorzelski, M.; Schaarschmidt, B. M.; Lang, Stephan; Kersting, David; Nader, M.; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel;
    PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S229
  • Kurreck, Annika; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander; von Weikersthal, Ludwig; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel Helga Sophie; Hoppe, Beeke; Kind, Andreas Jay; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Predictive and prognostic value of carcinoembryonic antigen (CEA) on maintenance therapy with 5-fluoruracil/leucovorin plus panitumumab or 5-fluoruracil/leucovorin alone in RAS wildtype metastatic colorectal cancer : Evaluation of the phase II PanaMa trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 3587
  • Stintzing, Sebastian; von Weikersthal, Ludwig; Fuchs, Martin; Kaiser, Florian; Heinrich, Kathrin; Modest, Dominik Paul; Hofheinz, Ralf; Decker, Thomas; Gerger, Armin; Angermeier, Stefan; Rumpold, Holger; Dickhut, Andreas; Öhler, Leopold; Gruenberger, Birgit; Niedersuess -Beke, Dora; Sandmann, Matthias; Winder, Thomas; Kasper, Stefan; Prager, Gerald; Heinemann, Volker
    Randomized study to investigate a switch maintenance concept with 5-FU plus bevacizumab after FOLFIRI plus cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab : Report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114)
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 3519
  • Heinemann, V.; Fischer von Weikersthal, L.; Fuchs, M.; Kaiser, F.; Heinrich, K.; Modest, D.; Hofheinz, R.; Decker, T.; Gerger, A.; Angermeier, S.; Rumpold, H.; Dickhut, A.; Öhler, L.; Grünberger, B.; Niedersüß-Beke, D.; Sandmann, M.; Kasper, Stefan; Prager, G.; Stintzing, S.
    SO-16 FIRE-4 (AIO-KRK-0114) : Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab – secondary endpoint
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 4, S. 363 - S364
  • Pabst, K. M.; Trajkovic-Arsic, M.; Cheung, P. F.; Kessler, Lukas; Hirmas, N.; Nader, M.; Bartel, T.; Schaarschmidt, B. M.; Kasper, Stefan; Siveke, Jens T.; Hamacher, R.; Schmidt, H. H. J.; Ingenwerth, M.; Herrmann, Ken; Fendler, Wolfgang P.;
    Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S192 - S193
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Gruenwald, V.; von Tresckow, Bastian; Hanoun, C.; Aigner, Clemens; Glas, M.; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.;
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S119 - S120
  • Klinghammer, K.; Graeven, U.; Ivanyi, P.; Dietz, A.; Hahn, D.; Hackenberg, S.; Kasper, Stefan; Fietkau, R.; Moulin, J.-C.; Pink, D.; Schaaf, M.; Grünwald, Viktor;
    ELDORANDO : Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 56 - 57
  • Pogorzelski, M.; Lauri, F.; Hilser, T.; Hense, Jörg; Ting, Saskia; Kansy, B.; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Zaun, G.; Grünwald, V.; Schuler, Martin; Kasper, Stefan
    Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 812
  • Modest, Dominik Paul; Karthaus, Meinolf; Frühauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Von Weikersthal, Ludwig Fischer; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Jarosch, Armin; Horst, David; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja
    Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212)
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 3503 - 3503
  • Saavedra Santa Gadea, O.; Greil, R.; de Jonge, M.J.A.; Tan, D.; Jerusalem, G.; Damian, S.; Grell, P.; Wainberg, Z.; Wolf, J.; Joerger, M.; Carlino, M.S.; Kasper, Stefan; Yap, T.A.; Otero, J.; Yang, X.; Nesbitt, V.; Kim, J.; Lee, L. Ho; Choudhury, S.; Leal, T.A.
    Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 552 - S553
  • Seufferlein, Thomas; Ettrich, Thomas Jens; Stein, Alexander; Arnold, Dirk; Prager, Gerald W.; Kasper, Stefan; Niedermeier, Michael; Müller, Lothar; Kubicka, Stefan; Koenig, Alexander; Büchner-Steudel, Petra; Wille, Kai; Kestler, Angelika M. R.; Berger, Andreas W.; Perkhofer, Lukas; Lausser, Ludwig; Kestler, Hans A.;
    Predicting resistance to first-line FOLFOX plus bevacizumab in metastatic colorectal cancer : Final results of the multicenter, international PERMAD trial
    2021 Gastrointestinal Cancers Symposium, 15-17 January 2021, online,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 3, Supplement, S. 115 - 115
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the Esophagus
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 154 - S155
  • Kasper, Stefan; Goetze, Thorsten Oliver; Stintzing, Sebastian; Hofheinz, Ralf Dieter; Sinn, Marianne; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Keitel, Verena; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Kolov, Alexander; Edelmann, Thomas; Stein, Alexander; Trarbach, Tanja; Junge, Sabine; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer : Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316)
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 3566 - 3566
  • Stintzing, Sebastian; Heinrich, Kathrin; Tougeron, David; Modest, Dominik Paul; Schwaner, Ingo; Euker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Mueller, Christian; Burkart, Christof; Reinacher-Schick, Anke C.; Kasper, Stefan; Fischer von Weikersthal, Ludwig; Krammer-Steiner, Beate; Prager, Gerald W.; Taieb, Julien; Heinemann, Volker
    Randomized study to investigate FOLFOXIRI plus either bevacizumab or cetuximab as first-line treatment of BRAF V600E-mutant mCRC : The phase-II FIRE-4.5 study (AIO KRK-0116)
    In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 3502 - 3502
  • Gruenwald, V.; Graeven, U.; Ivanyi, P.; Dietz, A.; Hahn, D.; Hackenberg, S.; Kasper, Stefan; Fietkau, R.; Moulin, J-C.; Pink, D.; Schaaf, M.; Klinghammer, K.
    Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 807 - S808
  • Kasper, Stefan; Hofheinz, R.D.; Stintzing, S.; Götze, T.O.; Sinn, M.; Dechow, T.; Ettrich, T.J.; Keitel, V.; Graeven, U.; Fischer von Weikersthal, L.; Kolov, A.; Edelmann, T.; Stein, A.; Trarbach, T.; Junge, S.; Pauligk, C.; Virchow, I.; Siveke, Jens; Al-Batran, S-E.; Schuler, Martin
    Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIO
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S427 - S428
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael;
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137
  • Kasper, Stefan; zur Hausen, Gerrit; Stein, Alexander; Stintzing, Sebastian; Berger, Andreas; Loges, Sonja; Hofheinz, Ralf; Trarbach, Tanja; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Goetze, Thorsten Oliver; Hagen, Volker A.; Burock, Susen; Hoffmeister, Albrecht; Dechow, Tobias Nicolaas; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. TPS3617 - TPS3617
  • Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Becker, Karl Friedrich; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stephanie E.; Weber, Wolfgang; Haller, Bernhard; Angele, Martin K.; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Zimmermann, Jens Peter; Algül, Hana; Schmid, Roland M.; Schwaiger, Markus; Siveke, Jens
    PET-directed combined modality therapy for gastroesophageal junction cancer : First results of the prospective MEMORI trial
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 4018 - 4018
  • Kraemer, Alwin; Stein, Alexander; Huebner, Gerdt; Stahl, Michael; Kasper, Stefan; Kretzschmar, Albrecht; Kohne, Claus-Henning; Gruenwald, Viktor; Hofheinz, Ralf; Schuette, Katharina; Loeffler, Harald; Bokemeyer, Carsten; Folprecht, Gunnar
    Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP) : Results of a multi-center randomized phase II AIO trial
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 4120
  • Meric-Bernstam, Funda; Sandhu, Shahneen Kaur; Hamid, Omid; Spreafico, Anna; Kasper, Stefan; Dummer, Reinhard; Shimizu, Toshio; Steeghs, Neeltje; Lewis, Nancy; Talluto, Craig C.; Dolan, Sinead; Bean, Andrew; Brown, Robert; Trujillo, Damian; Nair, Nitya; Luke, Jason J.
    Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 2507 - 2507
  • Seufferlein, Thomas; Lausser, Ludwig; Stein, Alexander; Prager, Gerald W.; Kasper, Stefan; Niedermeier, Michael; Müller, Lothar; Kubicka, Stefan; Koenig, Alexander; Buechner-Steudel, Petra; Wille, Kai; Perkhofer, Lukas; Hann, Alexander; Berger, Andreas Wolfgang; Arnold, Dirk; Kestler, Hans; Ettrich, Thomas Jens
    A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab : First results of the PERMAD trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e15545 - e15545
  • Cao, J.; Wiesweg, Marcel; Fuchs, M.; Stein, A.; Karthaus, M.; Lettmaier, S.; Kretzschmar, A.; Draube, A.; Ettrich, T.; Rüssel, J.; Müller, C.; Rafiyan, M.-R.; Borchert, K.; Schuler, Martin; Kasper, Stefan;
    Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 289
  • Slaski, C.; Kasper, Stefan; Paul, Andreas; Gerken, G.; Schmid, Kurt Werner; Meiler, Johannes; Teckelnborg, K.; Dechene, Alexander; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.;
    Evaluation of prognostic markers in patients (pts) with advanced gastric cancer (GC) and adenocarcinoma of the gastroesophageal junction (AEG) treated with systemic chemothearpy (ctx) at the West German Cancer Center
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 67
  • Kasper, Stefan; Gillison, M. L.; Blumenschein, G.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Harrington, K.; Vokes, Everett E.; Even, C.; Worden, F.; Saba, N. F.; Docampo, L. C. I.; Haddad, R.; Rordorf, T.; Kiyota, N.; Makoto, T.; Lynch, M.; Kopit, J.; Ferris, R. L.;
    Nivolumab (Nivo) vs Investigator‘s Choice (IC) for Platinum-Refractory (PR) Recrrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN; CheckMate 141) : Outcomes in First-line (1L) R/M Patients (Pts) and Updated Safety and Efficacy
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 96
  • Ferris, Robert L.; Blumenschein, George R.; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L.
    Nivolumab (Nivo) vs investigator's choice (IC) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) : 2-yr outcomes in the overall population and PD-L1 subgroups of CheckMate 141
    In: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,
  • Waberer, Lisa; Homann, Nils; Wirtz, Ralph M.; Schmalenberg, Harald; Haag, Georg Martin; Schuler, Martin; Kasper, Stefan; Goetze, Thorsten Oliver; Pauligk, Claudia; Hofheinz, Ralf; Al-Batran, Salah-Eddin
    PD-L1 mRNA expression in patients with resectable gastric cancer and adenocarcinoma of the oesophago-gastric junction undergoing perioperative chemotherapy : Results from the FLOT4 phase III trial of the AIO
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e24277 - e24277
  • Wiesweg, Marcel; Reis, Henning; Köster, T.; Goetz, M.; Worm, K.; Herold, T.; Paul, Andreas; Dechene, Alexander; Schumacher, B.; Markus, P.; Virchow, I.; Kostbade, K.; Wolf, N.; Zaun, G.; Metzenmacher, M.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 55
  • Stein, G.; Stelmach, Patrick; Kasper, Stefan; Paul, Andreas; Wedemeyer, Heiner H.; Schmid, Kurt Werner; Schumacher, B.; Markus, P.; Siffert, Winfried; Schuler, Martin; Bachmann, Hagen Sjard; Virchow, I.;
    The prognostic impact of UDP-glucuronyltransferase 1A1*1 (UGT1A1*1) polymorphism in patients with advanced colorectal and non-colorectal cancer treated with irinotecan-based systemic chemotherapies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 122 - 123
  • Ferris, R. L.; Blumenschein, G. R.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Harrington, K.; Kasper, Stefan; Vokes, E. E.; Even, C.; Worden, F.; Saba, N. F.; Docampo, L.; Haddad, R. I.; Rordorf, T.; Kiyota, N.; Tahara, M.; Lynch, M.; Li, L.; Gillison, M.;
    Two-year Update From CheckMate 141 : Outcomes With Nivolumab (Nivo) vs Investigator's Choice (IC) in Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the Overall Population and PD-L1 Subgroups
    2018 Multidisciplinary Head and Neck Cancers Symposium ; Expanding Treatment Horizons ; February 15-17, 2018, Scottsdale, Arizona, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 100 (2018) Nr. 5, S. 1317 - 1317
  • Licitra, L.; Ferris, R. L.; Blumenschein, G.; Harrington, K. J.; Guigay, J.; Kasper, Stefan; Saba, N. F.; Haddad, R.; Kiyota, N.; Monga, M.; Lynch, M.; Li, L.; Gillison, M. L.; Fayette, J.;
    Nivolumab vs investigator's choice (IC) in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) : treatment effect on clinical outcomes by best overall response in checkmate 141
    42nd ESMO Congress (ESMO 2017) ; 8-12 September 2017, Madrid, Spain,
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5, S. v377 - v378
  • Haddad, R.; Blumenschein, G.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Kasper, Stefan; Vokes, Everett E.; Worden, F.; Saba, N. F.; Tahara, M.; Concha-Benavente, F.; Monga, M.; Lynch, M.; Li, L.; Shaw, J. W.; Gillison, M. L.; Harrington, K. J.; Ferris, R. L.;
    Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 study : A biomarker analysis and updated clinical outcomes
    42nd ESMO Congress (ESMO 2017) ; 8-12 September 2017, Madrid, Spain,
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5, S. v372 - v373
  • Lückerath, M.; Kasper, Stefan; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Meiler, Johannes; Wiesweg, M.; Neuhaus, I.; Dechene, Alexander; Mende, B.; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.;
    Evaluation of prognostic markers in patients (pts) with metastatic colorectal cancer (mCRC) treated with a bevacizumab (bev) based chemotherapy (ctx) at the West German Cancer Center
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 77
  • Pogorzelski, M.; Hilser, T.; Ting, Saskia; Vossebein, I.; Gauler, Thomas; Abendroth, A.; Lang, Stephan; Stuck, Boris; Abu-Jawad, J.; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 307 - 308
  • Abendroth, A.; Markus, M.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Evaluation of systemic inflammatory response (SIR) markers in advanced biliary tract cancer (ABTC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 5 - 6
  • Markus, M.; Kasper, Stefan; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Abendroth, A.
    Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. S 5, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz, S. 4 - 5
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Dechene, Alexander; Schumacher, B.; Kaiser, Gernot Maximil; Schuler, Martin; Kasper, Stefan;
    Prognostische Faktoren bei Patienten mit fortgeschrittenen Pankreaskarzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist Jg. 56 (2015) Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 38 - 39
  • Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Bockisch, Andreas; Dechene, Alexander; Forsting, Michael; Schuler, Martin; Kasper, Stefan;
    Prognostische Faktoren bei Patienten mit fortgeschrittenen cholangiozellulären Karzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist Jg. 56 (2015) Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 37
  • Kasper, Stefan; Möhler, Markus; Hegewisch-Becker, Susanna; Overkamp, Friedrich; Bechstein, Wolf O.; Kullmann, Frank; Lang, Hauke; Schön, Michael; Smith-Machnow, Victoria; Seehofer, Daniel; Vöhringer, Matthias; Geissler, Michael; Greil, Richard; Heike, Michael; Heinemann, Volker; Lordick, Florian; Galle, Peter R.; Schimanski, Carl Christoph
    A randomized, double-blind, placebo-controlled, multicenter, binational, phase II trial of immunotherapy with L-BLP25 (tecemotide) in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, suppl., S. TPS3658
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Dechene, Alexander; Kostbade, K.; Schuler, Martin; Trarbach, Tanja;
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) - Primary endpoint analysis of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 99 - 100
  • Köhler, Johannes; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.;
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227
  • Gauler, Thomas; Pogorzelski, M.; Ting, Saskia; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Lang, Stephan; Bergmann, Christoph; Abu Jawad, Jehad; Markowetz, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 76
  • Kasper, Stefan; Ting, Saskia; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Worm, K.; Schmid, Kurt Werner; Markus, P.; Paul, Andreas; Dechene, Alexander; Forsting, Michael; Kostbade, K.; Trarbach, Tanja; Schuler, Martin;
    Molecular and clinical predictors of the efficacy of cetuximab in combination with mFOLFOX6 in 1st line treatment of patients (pts) with metastatic colorectal cancer (mCRC) – subgroup analyses of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 100 - 101
  • Kasper, Stefan; Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ)
    Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 51
  • Welt, Anja; Kasper, Stefan; Tewes, Mitra; Aktas, B.; Hoffmann, Oliver; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Palmer, M. R.; Lee, B. H.; Wendling, J.; Kossow, J.; Scheulen, Max Ernst; Lehnerdt, C.; Kohl, M.; Derks, C.; Slottky, S.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19
  • Abendroth, A.; Abramczyk, M.; Nourredine, R.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Bockisch, Andreas; Forsting, Michael; Schuler, Martin; Kasper, Stefan;
    Prognostic factors in patients (pts) with advanced cholangiocellular carcinoma (CCC) receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 122 - 123
  • Abendroth, A.; Nourredine, R.; Abramczyk, M.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin; Kasper, Stefan;
    Prognostic factors in patients with pancreatic cancer receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ), one of the 12 Oncology Centers of Excellence in Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 123 - 124
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3
  • Kasper, Stefan; Breitenbücher, Frank; Markowetz, J.; Reis, Henning; Ting, Saskia; Worm, K.; Meiler, Johannes; Schmid, Kurt Werner; Trarbach, Tanja; Schuler, Martin;
    Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 116 - 117
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 263
  • Tewes, Mitra; Kasper, Stefan; Aktas, B.; Hoffmann, A.; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Kern, P.; Scheulen, Max Ernst; Skottky, S.; Peters, M.; Schlegel, R.; Lee, B. H.; Palmer, M. R.; Monahan, J. E.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Welt, Anja;
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Oncology Research and Treatment Jg. 36 (2013) Nr. Suppl. 7, S. 157
  • Even, A.; Kasper, Stefan; Breitenbucher, F.; Pogorzelski, M.; Hoffarth, S.; Trarbach, Tanja; Schuler, Martin;
    Targeting NF-kappa B and PLK-1 to overcome RAS-mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 33
  • Bücher/Sammelwerke/Tagungsbände

  • Kasper, Stefan
    Therapeutische Modulation onkogener Signaltransduktion bei malignen Erkrankungen und Mechanismen der Resistenzentwicklung
    Duisburg, Essen (2014) 1 CD-ROM